Charles River Laboratories International Inc (CRL) Stock Analysis
Verdict: WATCH (do not buy)
Earnings beat and book-to-bill recovery trigger a tactical rally, but extreme valuation premiums and high debt cap the long-term upside.
Investment score: 58/100
Analysis as of
Is Charles River Laboratories International Inc stock worth reviewing? The TradeMates thesis
CRL is experiencing a sentiment-driven recovery following a positive Q2 earnings surprise. However, fundamental risks including high net debt (12.8x EBITDA) and aggressive insider selling suggest the rally may be nearing exhaustion.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 40/100 (weight 15%)
- Technical Momentum: 85/100 (weight 15%)
- Earnings Quality: 90/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 45/100 (weight 10%)
- Risk-Adjusted Return: 50/100 (weight 15%)
Charles River Laboratories International Inc opportunities and risks
What speaks for CRL
- Book-to-Bill Inflection
What speaks against CRL
- Extreme Valuation Disconnect
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CRL | n/a | 3.2x | 70.2x | 32.2% | -6.0% | 2.9% |
| ILMN | 37.2x | 6.8x | 23.4x | 66.8% | 18.4% | 3.1% |
| MTD | 32.3x | 7.0x | 24.1x | 59.3% | 21.9% | 3.0% |
| WST | 44.7x | 7.5x | 29.9x | 36.8% | 17.0% | 1.8% |
| MEDP | 33.6x | 5.9x | 26.5x | 28.8% | 17.7% | 4.5% |
| TEM | n/a | 5.8x | n/a | 64.0% | -17.8% | -3.3% |
| Peer median | 33.6x | 6.8x | 24.1x | 59.3% | 17.7% | 3.0% |
Frequently asked questions about Charles River Laboratories International Inc (CRL)
Is CRL stock a good investment?
The TradeMates model rates Charles River Laboratories International Inc as WATCH (do not buy) with an investment score of 58/100. CRL is experiencing a sentiment-driven recovery following a positive Q2 earnings surprise. However, fundamental risks including high net debt (12.8x EBITDA) and aggressive insider selling suggest the rally may be nearing exhaustion. This is algorithmic model output, not personal investment advice.
Is CRL stock a buy?
The TradeMates model verdict for CRL is WATCH (do not buy) with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.